Hans-Peter Gerber

Insider Reports History

Entity
Individual
Location
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ Edward C. Albini as attorney-in-fact for Hans-Peter Gerber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans-Peter Gerber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Restricted Stock Unit (RSU) 150K $706K $4.71 Sep 18, 2023 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Restricted Stock Units (RSUs) 45K $204K $4.54 Mar 5, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 175K Sep 18, 2023 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy Common Stock) 60K Mar 5, 2024 Direct

Insider Reports Filed by Hans-Peter Gerber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Mar 5, 2024 2 $0 4 Mar 7, 2024 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 2 $0 4 Sep 19, 2023 Chief Scientific Officer
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 0 $0 3 Sep 19, 2023 Chief Scientific Officer